Prevention and Treatment of Ischemic Stroke
Transcript of Prevention and Treatment of Ischemic Stroke
Grading Key★★★★★ = outstanding; ★★★★ = excellent; ★★★ = good;★★ = fair; ★ = poor.
Book Review
© 2004 Mayo Foundation for Medical Education and Research
Prevention and Treatment of Ischemic Stroke, edited byScott E. Kasner and Philip B. Gorelick, 416 pp, with illus, $99,Newton, Mass, Butterworth-Heinemann (telephone: 800-366-2665), 2004, ISBN 0-7506-7464-4
Type and Scope of Book: A comprehensive multiauthoredreview of the treatment and secondary prevention of acuteischemic stroke.Contents: In this 19-chapter text, the editors have compiled areview of acute ischemic stroke treatment and secondary pre-vention measures, including a discussion of thrombolytics,antithrombotics, and risk factor modification. The first 2 chap-ters provide an introductory overview. Chapters 3 through 8discuss particular mechanisms of ischemic stroke(cardioembolic, large-vessel atherosclerosis, small-vessel dis-ease, etc) and review diagnosis and evidence-based treatmentdata. Chapters 9 and 10 address secondary prevention of is-chemic stroke, including the use of antithrombotics and ath-erosclerotic risk factor modification. The second half of thetext focuses on the management of acute ischemic stroke. Apractical review of clinical and diagnostic evaluation leadsinto a chapter that extensively reviews thrombolytic therapy.Strengths: The text is very readable. Many chapters presentevidence-based data that are remarkably up-to-date and com-prehensive. The second half of the book, devoted to acuteischemic stroke management, provides both evidence-basedrecommendations and practical advice on the approach toaffected patients.Deficiencies: In multiauthored texts, the contributors bringvarious styles to individual chapters, which can have bothpositive and negative effects. While most chapters in this bookprovide evidence-based information and practical recommen-dations, some chapters lack practical advice that practitionersneed when data are conflicting. In addition, coagulation disor-ders, genetic causes of ischemic stroke, and nonvasculiticarteriopathies seem to be underrepresented, although they areuncommon in the general population as well.Recommended Readership: Neurologists or internists whotreat patients with ischemic stroke.Overall Grading: ����
Kelly D. Flemming, MD, Department of Neurology, MayoClinic College of Medicine, Rochester, Minn
For personal use. Mass reproduce only with permission from Mayo Clinic Proceedings.